Posts by bivey

Bahr wins University of North Carolina’s highest honor

Posted

Bahr wins University of North Carolina’s highest honor

Video Available On May 19, 2017 Ben Bahr, Ph.D., the William C. Friday Chair and Distinguished Professor of Microbiology and Biochemistry at the University of North Carolina at Pembroke was recognized as the 2017 Oliver Max Gardner Award winner. The award – the highest honor given by the University and established by the will of former Governor O. Max Gardner – recognizes faculty who have “made the greatest contribution to the welfare of the human race.” Bahr received a 2014 CART Grant.  In addition to delivering critical research results (and attracting follow-on funding) Bahr has been a true partner in the CART effort to cure Alzheimer’s through cutting...

Read More

Ikezu 2014 Grant leads to acclaim & funding

Posted

Ikezu 2014 Grant leads to acclaim & funding

Last summer, Tsuneya Ikezu, M.D., Ph.D., Professor of Pharmacology and Neurology at Boston University School of Medicine received the Inge Grundke-Iqbal Award for Alzheimer’s Research at the Alzheimer’s Association International Conference (AAIC) in Toronto, Ontario, July 24-28, 2016.  Dr. Ikezu, whose research focuses on molecular therapeutic intervention of neurodegenerative and neuropsychiatric disorders, gave a plenary lecture at the conference. The Inge Grundke-Iqbal Award for Alzheimer’s Research recognizes the senior author of the most impactful study on the biology of Alzheimer’s disease and related conditions published during the two calendar years...

Read More

Share CART at RI in Atlanta

Posted

Share CART at RI in Atlanta

Are you attending the Rotary International Convention in Atlanta in June? Would you like to donate an hour to work the CART booth in the House of Friendship? This is your chance to share the story of CART with Rotarians from around the globe. If you are a Rotarian and would like to volunteer, click here. If you are a spouse or friend of a Rotarian and would like to volunteer, click here. Questions?  Contact Norman Rogers – 910-616-1205 or...

Read More

Claudio Torres | CART Fund 2017 Grant

Posted

Claudio Torres | CART Fund 2017 Grant

Research Project:  Neuron Senescence as Mediator of Neurodegeneration in Alzheimer’s disease The CART Fund will award Claudio Torres, Ph.D., Drexel University College of Medicine, a 2017 research grant in the amount of $50,000. The grant will be awarded on May 9, 2017 at the Annual Meeting of The CART Fund in Columbia, SC. Summary of Research Project: Alzheimer’s Disease (AD) currently affects about 5.4 million Americans and currently has no cure. Aging is the greatest risk factor for AD; however, the mechanisms of aging that predispose the brain to the development of the disease are still largely unknown. Cellular senescence is a hallmark of aging that may...

Read More

Michael Karin | CART Fund 2017 Grant

Posted

Michael Karin | CART Fund 2017 Grant

Research Project:   Inhibition of NLRP3 inflammasome activation – a new strategy for prevention and treatment of Alzheimer’s Disease and late onset neurodegeneration. The CART Fund will award Michael Karin Ph.D., University of California, San Diego School of Medicine, a 2017 research grant in the amount of $150,000. The grant will be awarded on May 16, 2017 at a meeting of The CART Fund in Orlando, FL. Summary of Research Project Alzheimer’s disease (AD) is the most common form of age-related dementia that exerts an incredible emotional and economic toll on our aging society. Currently, there are no effective treatments for AD or preventive measures that can...

Read More

Tong Li | CART Fund 2017 Grant

Posted

Tong Li | CART Fund 2017 Grant

Research Project:  Determining the contributions of age and neuroinflammation on the pathological conversion of tau The CART Fund will award Tong Li, Ph.D., Johns Hopkins University School of Medicine, a 2017 research grant in the amount of $75,000. The grant will be awarded on May 9, 2017 at the Annual meeting of The CART Fund in Columbia, SC. Alzheimer’s disease (AD), the most common form of dementia and a devastating illness for the elderly, is characterized by built-up of clumped proteins observed inside (called tau aggregates) and outside (called amyloid-beta (Aβ) plaques) of nerve cells that lead to memory problems and eventual loss of these cells. Past and...

Read More

Tsuneya Ikezu | CART Fund 2017 Grant

Posted

Tsuneya Ikezu | CART Fund 2017 Grant

Research Project: Therapeutic evaluation of novel tau kinase inhibitors in Alzheimer’s disease The CART Fund is pleased to announce that Tsuneya Ikezu, MD, Ph.D., Boston University School of Medicine, has been selected to receive a 2017 Alzheimer’s research grant in the amount of $100,000. The grant will be awarded on May 9, 2017 at the annual meeting of The Coins for Alzheimer’s Research Trust Fund (CART Fund) in Columbia, SC. Dr. Ikezu’s team is interested in the  development of small molecule drugs that would suppress the aggregation of tau protein in the brain, as the accumulation of this protein is believed to cause Alzheimer’s disease. The new compound,...

Read More

Philip F. Copenhaver | CART Fund 2017 Grant

Posted

Philip F. Copenhaver | CART Fund 2017 Grant

Research Project: A novel modulator of membrane estrogen receptors for treating AD Key Collaborator: Dr. Joseph Quinn, MD The CART Fund will award Philip Copenhaver, Ph.D., Oregon Health & Science University, a 2017 Alzheimer’s research grant in the amount of $75,000. The grant will be awarded on May 16, 2017 at a meeting of The CART Fund in Orlando, Florida. Alzheimer’s Disease (AD) involves the abnormal buildup of beta-amyloid and tau levels in the brain, but clinical trials designed to prevent their accumulation have been unsuccessful.   In contrast, a drug that could protect nerve cells against these toxic proteins might provide an alternative strategy for...

Read More

Christelle Anaclet | CART Fund 2017 Grant

Posted

Christelle Anaclet | CART Fund 2017 Grant

Research Project:  Sleep enhancement: a strategy to improve cognitive performance in adult and Alzheimer’s disease mouse models The CART Fund will award Christelle Anaclet, Ph.D., University of Massachusetts Medical School, the top 2017 Alzheimer’s research grant in the amount of $250,000. The grant will be awarded on May 9, 2017 at the Annual meeting of The CART Fund in Columbia, SC. Our goal is to reduce the burden of Alzheimer’s disease. Cognitive impairment and sleep disruption represent two of the most disabling symptoms of Alzheimer’s disease and are the primary bases for institutionalization. Given that sleep disruption is known to cause cognitive...

Read More

CART Fund 2017 Alzheimer’s Research Grants

Posted

CART Fund 2017 Alzheimer’s Research Grants

The Coins for Alzheimer’s Research Trust Fund (CART) will award $700,000 in Alzheimer’s research grants in May 2017. Awards will be made to six researchers from US institutions. The 2017 grants mark two records for CART. The $700,000 figure is the highest dollar amount of grants ever awarded by the organization. After all, CART grants are funded by the generosity of Rotarians, starting with donations of coins and cash at weekly Rotary Club meetings. Since CART’s inception in 1995, CART has always put one hundred percent of all donations to research grants. It took four years of donations to fund the first grant of $100,000 in 1999. Remarkably, the 2017 grants were...

Read More

DIY Club CART Program (15 min.)

Posted

DIY Club CART Program (15 min.)

If your club is interested in supporting Alzheimer’s research, check out this Do-It-Yourself Club CART Program. Whether Coins for Alzheimer’s Research Trust (CARTFUND.org) is new to your club, or a long-supported effort, here is a do-it-yourself, ready-to-go CART program. 1 ) Stream the 15 minute version of the made-for-TV episode: “Remembering No More” (15 minutes, free of commercial advertisements) 2 ) Q&A using Frequently Asked Questions about CART Join CART’s efforts in the prevention and cure for Alzheimer’s disease. The CART Fund collects voluntarily contributions and makes periodic awards to qualified US institutions...

Read More

Cao Research Licensed by Alzamend Neuro Inc.

Posted

Cao Research Licensed by Alzamend Neuro Inc.

Follow-on Funding from Regulation A+ Tier II SEC Qualified Offering The CART Fund is pleased to announce follow-on funding for the research project begun by Chuanhai Cao, MPH, Ph.D. with a 2014 CART Grant. Alzamend Neuro has licensed Cao’s patented mutant peptide for use in immunotherapy from the University of South Florida. Alzamend aims to support the continuing research by the team at the USF Health Byrd Alzheimer’s Institute and develop and commercialize their results into meaningful solutions. The funding for Cao’s continued research will come from a Regulation A+ Tier II SEC Qualified Offering launched by Alzamend Neuro Inc. Reg. A+ Tier II rules allow for...

Read More